- Home
- NIU vs ABEO Comparison
NIU vs ABEO Comparison
Compare NIU & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NIU | ABEO |
|---|---|---|
| Founded | 2014 | 1974 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.6M | 281.0M |
| IPO Year | 2018 | 1980 |
Fundamental Metrics
Financial Performance| Metric | NIU | ABEO |
|---|---|---|
| Price | $3.11 | $5.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.20 |
| AVG Volume (30 Days) | 681.2K | ★ 1.1M |
| Earning Date | 11-17-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | ★ $625,182,280.00 | $400,000.00 |
| Revenue This Year | $42.51 | N/A |
| Revenue Next Year | $23.71 | $1,589.77 |
| P/E Ratio | ★ N/A | $4.08 |
| Revenue Growth | ★ 50.99 | N/A |
| 52 Week Low | $1.75 | $3.93 |
| 52 Week High | $5.67 | $7.54 |
Technical Indicators
Market Signals| Indicator | NIU | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 52.20 |
| Support Level | $3.12 | $4.98 |
| Resistance Level | $3.30 | $5.34 |
| Average True Range (ATR) | 0.15 | 0.24 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 20.45 | 37.18 |
Price Performance
Historical ComparisonAbout NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.